Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling

被引:4
|
作者
De Sutter, Pieter-Jan [1 ]
Rossignol, Phebe [1 ]
Breens, Lien [1 ]
Gasthuys, Elke [1 ]
Vermeulen, An [1 ]
机构
[1] Univ Ghent, Dept Bioanal, B-9000 Ghent, Belgium
关键词
physiologically based pharmacokinetics (PBPK); pharmacokinetics; neonates; volume of distribution; allometric scaling; developmental pharmacology; HUMAN SERUM-ALBUMIN; SINGLE-DOSE PHARMACOKINETICS; POPULATION PHARMACOKINETICS; PROTEIN-BINDING; PRETERM INFANTS; CEFTAZIDIME PHARMACOKINETICS; CLINICAL PHARMACOKINETICS; MORPHINE PHARMACOKINETICS; IMIPENEM-CILASTATIN; HEALTHY-VOLUNTEERS;
D O I
10.3390/pharmaceutics15092348
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The volume of distribution at steady state (Vss) in neonates is still often estimated through isometric scaling from adult values, disregarding developmental changes beyond body weight. This study aimed to compare the accuracy of two physiologically based pharmacokinetic (PBPK) Vss prediction methods in neonates (Poulin & Theil with Berezhkovskiy correction (P & T+) and Rodgers & Rowland (R & R)) with isometrical scaling. PBPK models were developed for 24 drugs using in-vitro and in-silico data. Simulations were done in Simcyp (V22) using predefined populations. Clinical data from 86 studies in neonates (including preterms) were used for comparison, and accuracy was assessed using (absolute) average fold errors ((A)AFEs). Isometric scaling resulted in underestimated Vss values in neonates (AFE: 0.61), and both PBPK methods reduced the magnitude of underprediction (AFE: 0.82-0.83). The P & T+ method demonstrated superior overall accuracy compared to isometric scaling (AAFE of 1.68 and 1.77, respectively), while the R & R method exhibited lower overall accuracy (AAFE: 2.03). Drug characteristics (LogP and ionization type) and inclusion of preterm neonates did not significantly impact the magnitude of error associated with isometric scaling or PBPK modeling. These results highlight both the limitations and the applicability of PBPK methods for the prediction of Vss in the absence of clinical data.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
    Miroslav Dostalek
    Iain Gardner
    Brian M. Gurbaxani
    Rachel H. Rose
    Manoranjenni Chetty
    Clinical Pharmacokinetics, 2013, 52 : 83 - 124
  • [32] The application of physiologically based pharmacokinetic modelling in the analysis of occupational exposure to perchloroethylene
    Loizou, GD
    TOXICOLOGY LETTERS, 2001, 124 (1-3) : 59 - 69
  • [33] Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal Antibodies
    Dostalek, Miroslav
    Gardner, Iain
    Gurbaxani, Brian M.
    Rose, Rachel H.
    Chetty, Manoranjenni
    CLINICAL PHARMACOKINETICS, 2013, 52 (02) : 83 - 124
  • [34] Physiologically based pharmacokinetic modelling of human exposure to 2-butoxyethanol
    Franks, SJ
    Spendiff, MK
    Cocker, J
    Loizou, GD
    TOXICOLOGY LETTERS, 2006, 162 (2-3) : 164 - 173
  • [35] Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women
    Amice, Basile
    Ho, Harvey
    Zhang, En
    Bullen, Chris
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [36] Physiologically based pharmacokinetic modelling in pregnancy: Model reproducibility and external validation
    Silva, Larissa L.
    Silvola, Rebecca M.
    Haas, David M.
    Quinney, Sara K.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (04) : 1441 - 1451
  • [37] Physiologically Based Pharmacokinetic Modelling of Cabotegravir Microarray Patches in Rats and Humans
    Kinvig, Hannah
    Rajoli, Rajith K. R.
    Pertinez, Henry
    Vora, Lalitkumar K.
    Volpe-Zanutto, Fabiana
    Donnelly, Ryan F.
    Rannard, Steve
    Flexner, Charles
    Siccardi, Marco
    Owen, Andrew
    PHARMACEUTICS, 2023, 15 (12)
  • [38] Physiologically based pharmacokinetic modelling of long-acting rilpivirine in pregnancy
    Atoyebi, S.
    Granana-Castillo, S.
    Siccardi, M.
    Waitt, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 186 - 187
  • [39] Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials
    Utembe, Wells
    Clewell, Harvey
    Sanabria, Natasha
    Doganis, Philip
    Gulumian, Mary
    NANOMATERIALS, 2020, 10 (07) : 1 - 32
  • [40] Physiologically based pharmacokinetic and pharmacodynamic modelling of alprazolam: Implications for anxiety and addiction
    Burkat, Paul M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (08) : 2569 - 2581